Large language models (LLMs) are poised to become a much bigger part of doctors’ clinical workflows, according to Scott Gottlieb, who served as commissioner of the FDA during the Trump administration.
He shared this take…
Continue Reading
What You Should Know:
– Grin, a virtual care platform for oral health, has secured a significant investment from CareQuest Innovation Partners. This funding will accelerate Grin’s mission to improve access to dental care, particularly…
Continue Reading
This week at the HLTH conference in Las Vegas, FDA Commissioner Robert Califf sat down with John Brownstein, chief innovation officer at Boston Children’s Hospital, to discuss the current state of healthcare AI, as…
Continue Reading
Introduction
Artificial Intelligence (AI) is rapidly transforming healthcare, offering revolutionary tools for diagnosis, treatment, and patient care. However, the complexity and potential risks associated with AI necessitate robust regulation to ensure its safe and effective…
Introduction
To improve access to preventive and reproductive healthcare, the U.S. Department of Health and Human Services (HHS) has proposed a rule to expand coverage for birth control and pre-exposure prophylaxis (PrEP). The proposed rule…
Introduction
In the ever-evolving healthcare industry, artificial intelligence (AI) is making significant strides, but it also raises critical quesGesund.ai open-sources a library of AI evaluation methods to address bias in clinical settings. Discover how this…
The Food and Drug Administration (FDA) has released its perspective on regulating AI in healthcare and biomedicine, stating that oversight needs to be coordinated across all regulated industries, international organizations and the U.S. government. The…
Continue Reading
What You Should Know:
– Gesund.ai, the clinical AI validation company, today announced the open sourcing of a comprehensive library of evaluation methodologies and frameworks to help developers and users address AI performance and potential bias…
Continue Reading
Introduction
PursueCare, a leader in virtual addiction treatment, has relaunched RESET and RESET-O, two FDA-cleared prescription digital therapeutics (PDTs), designed to help individuals struggling with substance use disorder (SUD) and opioid use disorder (OUD). Originally…
PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics for substance use disorder and opioid use disorder.RESET and RESET-O were initially developed and…
Continue Reading
